How to Buy Amylyx Pharmaceuticals Stock
Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Amylyx Pharmaceuticals stock last closed at $5.11, up 4.29% from the previous day, and has increased 182.32% in one year. It has overperformed other stocks in the Biotechnology industry by 2.59 percentage points. Amylyx Pharmaceuticals stock is currently +224.44% from its 52-week low of $1.58, and -29.71% from its 52-week high of $7.27.
There are currently 88.6M AMLX shares outstanding. The market capitalization of AMLX is $452.76M. In the last 24 hours, 1.04M AMLX shares were traded.
How to Buy Amylyx Pharmaceuticals Stock
Wondering how to invest in Amylyx Pharmaceuticals stock? Here's how.
- Choose where to buy Amylyx Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Amylyx Pharmaceuticals stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your method of payment and add your info.
- Evaluate Amylyx Pharmaceuticals stock: The Amylyx Pharmaceuticals ticker symbol is AMLX. Is Amylyx Pharmaceuticals stock a good investment? Should you buy shares of AMLX? How do AMLX's underlying business fundamentals look? Do top analysts think Amylyx Pharmaceuticals is a good buy? Why has AMLX's stock price moved recently? (Hint: Our stock research website can help you decide if AMLX is a good stock to buy).
- Execute your AMLX buy order: Decide if you will purchase AMLX shares at the current market price or use a limit order to purchase AMLX stock at a given price.
- Monitor your AMLX position: Create a watchlist to get live updates on your new investment in Amylyx Pharmaceuticals shares.
Step 1: Choose where to buy Amylyx Pharmaceuticals stock
You will need a brokerage account to access the NASDAQ market and buy AMLX shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, you need to fill out some personal information so you can invest in AMLX today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to open a new trading account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've created your account on the best stock broker app, you can securely and quickly fund your account:
Check out the walkthrough below if you need help transferring funds into your brokerage account.
Step 4: Evaluate Amylyx Pharmaceuticals stock
Once you have selected the best place to buy Amylyx Pharmaceuticals stock, it's very important to research their stock before you invest, so you can wrap your head around the risk as well as the opportunity.
Amylyx Pharmaceuticals stock at a glance
Amylyx Pharmaceuticals Fundamentals
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on AMLX's stock page.
Is AMLX stock undervalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge AMLX's intrinsic value.
Using relative valuations methods:
- AMLX could be undervalued based on its P/B ratio of 2.75x, relative to Biotechnology industry P/B ratio of 4.45x
You can do more valuation research on AMLX's stock here.
AMLX Financial Health Overview
Passed Health Checks:
- AMLX has a low debt to equity ratio of 0.18.
- There are more short-term assets than short-term liabilities on the AMLX balance sheet.
- AMLX has cash burn of 167804000. It has sufficient cash and short-term investments to cover this for at least one year.
- Total AMLX debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the AMLX balance sheet.
Failed Health Checks:
- AMLX has $177.95M in cash and short term investments. This is not enough to cover its annual cash burn of $167.80M.
- AMLX profit margin has gone down from 12.9% to -345.4% in the past year.
Is it a good time to buy Amylyx Pharmaceuticals stock, according to analysts?
Out of 3 sell side analysts who give forecasts on AMLX, the consensus analyst rating on AMLX is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are projecting on the Amylyx Pharmaceuticals stock forecast page.
AMLX Trading Indicators
AMLX Earnings
Last year, AMLX revenue was $87.37M. In the last five year, AMLX's revenue has increased by 127.75% per year. This was faster than the Biotechnology industry average of 45.66%.
Find out more about AMLX's earnings and revenue performance here.
Who is buying/selling AMLX?
In the past year, executives and large shareholders at AMLX have bought more shares than they have sold.
Camille L. Bedrosian, Chief Medical Officer of AMLX, was the latest AMLX insider to sell. They sold $43,077.48 worth of AMLX shares on Mar 31, 2025.
Dig into more about who owns AMLX shares here.
Does AMLX stock generate passive income?
No, Amylyx Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your AMLX buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price, use a limit order.
Click the Open button and eToro will execute the order.
If you want more help with buying stocks on eToro, click the helpful video below:
Step 6: Monitor your AMLX position
Now that you own some shares in AMLX, you'll want to keep up with your new investment.
Start a watchlist to keep track of your AMLX stock.
AMLX Feed
How to Buy Stock in Amylyx Pharmaceuticals
To summarize, here are the 6 steps you need to take to buy Amylyx Pharmaceuticals stock right now:
- Choose where to buy Amylyx Pharmaceuticals stock
- Open a brokerage account
- Deposit funds into your investment account
- Evaluate Amylyx Pharmaceuticals stock
- Execute your AMLX buy order
- Monitor your AMLX position
If you are looking for a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to get the latest scoop on your new investment in Amylyx Pharmaceuticals, click below.
More Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.